Blog

Dr. Maloney Discusses CAR T-Cell Therapy in Solid Tumors – OncLive

Dr. Maloney Discusses CAR T-Cell Therapy in Solid Tumors
OncLive
David G. Maloney, MD, PhD, member of the Clinical Research Division, Fred Hutchinson Cancer Research Center in Seattle, Washington, discusses using chimeric antigen receptor (CAR) T-cell therapy in solid tumors. Currently, the 2 approved indications

2017-11-01 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.